During the past decade, Praxis für Gefäßmedizin am Tegernsee conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis für Gefäßmedizin am Tegernsee" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Praxis für Gefäßmedizin am Tegernsee" are "Peripheral Arterial Disease" (1 trials) and "Superficial Vein Thrombosis" (1 trials). Many other conditions were trialed in "Praxis für Gefäßmedizin am Tegernsee" in a lesser frequency.

Most popular intervention types in "Praxis für Gefäßmedizin am Tegernsee" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AngioPress Intermittent pneumatic compression (IPC) Device" (1 trials), "Fondaparinux" (1 trials), "Medications and Standard walking exercises" (1 trials) and "Rivaroxaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxis für Gefäßmedizin am Tegernsee" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Praxis für Gefäßmedizin am Tegernsee". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Praxis für Gefäßmedizin am Tegernsee, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis für Gefäßmedizin am Tegernsee, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".